Local Consolidative Radiation Therapy
Showing 1 - 25 of >10,000
Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)
Recruiting
- Oligometastatic Disease
- +2 more
- Local Consolidative Radiation Therapy
- TKI
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Mar 11, 2022
Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer Trial in Mumbai (Local consolidative radiation therapy, Standard
Recruiting
- Oligometastatic Disease
- Metastatic Non Small Cell Lung Cancer
- Local consolidative radiation therapy
- Standard maintenance therapy as decided by the treating medical oncologist
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital, Parel
Mar 11, 2022
Oligometastatic Malignant Solid Tumor Trial in United States (Best Practice, Local Consolidation Therapy)
Recruiting
- Oligometastatic Malignant Solid Neoplasm
- Best Practice
- Local Consolidation Therapy
-
Tuscaloosa, Alabama
- +12 more
Jul 12, 2022
Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,
Recruiting
- Lung Adenocarcinoma
- +2 more
- Ipilimumab
- +5 more
-
Conroe, Texas
- +4 more
May 25, 2022
Colorectal Cancer Metastatic Trial in Philadelphia (Local consolidative therapy)
Withdrawn
- Colorectal Cancer Metastatic
- Local consolidative therapy
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 7, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV NSCLC AJCC v7 Trial in Denver, Houston, London (other, radiation, procedure)
Active, not recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Non-Small Cell Lung Cancer AJCC v7
- Clinical Observation
- +5 more
-
Denver, Colorado
- +2 more
Feb 10, 2022
Stage IV NSCLC Trial in Dallas (Stereotactic Body Radiation Therapy, Maintenance chemo)
Completed
- Stage IV Non-Small Cell Lung Cancer
- Stereotactic Body Radiation Therapy
- Maintenance chemotherapy
-
Dallas, TexasUT Southwestern Medical Center
Jun 30, 2022
Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Beijing (Esophagectomy)
Active, not recruiting
- Esophageal Squamous Cell Carcinoma
- Oligometastatic Disease
- Esophagectomy
-
Beijing, China
- +1 more
Jul 11, 2023
Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Not yet recruiting
- Stage III Lung Cancer AJCC v8
- +6 more
- Carboplatin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
May 14, 2021
Lung Cancer, Carcinoma, Non-Small Cell Lung Trial in Omaha (consolidative hypofractionated radiation therapy (hfRT), Durvalumab
Recruiting
- Lung Cancer
- Carcinoma, Non-Small Cell Lung
- consolidative hypofractionated radiation therapy (hfRT)
- Durvalumab 50 MG/ML
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jul 27, 2021
Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)
Not yet recruiting
- Mycosis Fungoides
- Imiquimod
- Radiation Therapy
- (no location specified)
Apr 29, 2023
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Worldwide (3-Dimensional Conformal Radiation Therapy (3D-CRT),
Suspended
- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer
- 3-Dimensional Conformal Radiation Therapy (3D-CRT)
- +7 more
-
Birmingham, Alabama
- +298 more
Jul 8, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Trial in United States
Recruiting
- Lung Non-Small Cell Carcinoma
- +5 more
- Osimertinib
- +2 more
-
San Francisco, California
- +3 more
Aug 17, 2022
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Recurrent Pancreatic Ductal Adenocarcinoma Trial in Amsterdam, Rotterdam, Utrecht (Additional stereotactic body radiation
Enrolling by invitation
- Recurrent Pancreatic Ductal Adenocarcinoma
- Additional stereotactic body radiation therapy
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
May 17, 2022
Collection of Head Images During Radiotherapy
Recruiting
- Head and Neck Neoplasms
- Radiation Therapy Complication
-
Blacktown, New South Wales, AustraliaBlacktown Hospital
Jan 25, 2023
Breast Cancer Trial (Radiation therapy)
Withdrawn
- Breast Cancer
- Radiation therapy
- (no location specified)
May 10, 2022
Localized Skin Lesion, Mycosis Fungoides Trial in Houston (Quality-of-Life Assessment, Questionnaire Administration, Radiation
Recruiting
- Localized Skin Lesion
- Mycosis Fungoides
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2022
Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)
Completed
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +2 more
Jul 11, 2022
Check the Local Response of Prostate Cancer to Radiation Therapy
Recruiting
- Prostatic Neoplasms
- Prostate Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 31, 2022
Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +1 more
Mar 29, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Breast Cancer Trial in Prague, Haifa, Candiolo (drug, radiation, device)
Withdrawn
- Breast Cancer
- ThermoDox (Thermally Sensitive Liposomal Doxorubicin)
- +2 more
-
Prague, Czechia
- +2 more
Mar 29, 2022